RT Journal Article
SR Electronic
T1 Machine learning-based classification of Alzheimer’s disease and its at-risk states using personality traits, anxiety, and depression
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.30.22282930
DO 10.1101/2022.11.30.22282930
A1 Waschkies, Konrad F.
A1 Soch, Joram
A1 Darna, Margarita
A1 Richter, Anni
A1 Altenstein, Slawek
A1 Beyle, Aline
A1 Brosseron, Frederic
A1 Buchholz, Friederike
A1 Butryn, Michaela
A1 Dobisch, Laura
A1 Ewers, Michael
A1 Fliessbach, Klaus
A1 Gabelin, Tatjana
A1 Glanz, Wenzel
A1 Goerss, Doreen
A1 Gref, Daria
A1 Janowitz, Daniel
A1 Kilimann, Ingo
A1 Lohse, Andrea
A1 Munk, Matthias H.
A1 Rauchmann, Boris-Stephan
A1 Rostamzadeh, Ayda
A1 Roy, Nina
A1 Spruth, Eike Jakob
A1 Dechent, Peter
A1 Heneka, Michael T.
A1 Hetzer, Stefan
A1 Ramirez, Alfredo
A1 Scheffler, Klaus
A1 Buerger, Katharina
A1 Laske, Christoph
A1 Perneczky, Robert
A1 Peters, Oliver
A1 Priller, Josef
A1 Schneider, Anja
A1 Spottke, Annika
A1 Teipel, Stefan
A1 Düzel, Emrah
A1 Jessen, Frank
A1 Wiltfang, Jens
A1 Schott, Björn H.
A1 Kizilirmak, Jasmin M.
YR 2023
UL http://medrxiv.org/content/early/2023/07/12/2022.11.30.22282930.abstract
AB Background Alzheimer’s disease (AD) is often preceded by stages of cognitive impairment, namely subjective cognitive decline (SCD) and mild cognitive impairment (MCI). While cerebrospinal fluid (CSF) biomarkers are established predictors of AD, other non-invasive candidate predictors include personality traits, anxiety, and depression, among others. There predictors offer non-invasive assessment and exhibit changes during AD development and preclinical stages.Methods In a cross-sectional design, we comparatively evaluated the predictive value of personality traits (Big Five), geriatric anxiety and depression scores, resting-state functional magnetic resonance imaging activity of the default mode network, apoliprotein E (ApoE) genotype, and CSF biomarkers (tTau, pTau181, Aβ42/40 ratio) in a multi-class support vector machine classification. Participants included 189 healthy controls (HC), 338 individuals with SCD, 132 with amnestic MCI, and 74 with mild AD from the multicenter DZNE-Longitudinal Cognitive Impairment and Dementia Study (DELCODE).Results Mean predictive accuracy across all participant groups was highest when utilizing a combination of personality, depression, and anxiety scores. HC were best predicted by a feature set comprised of depression and anxiety scores and participants with AD were best predicted by a feature set containing CSF biomarkers. Classification of participants with SCD or aMCI was near chance level for all assessed feature sets.Conclusion Our results demonstrate predictive value of personality trait and state scores for AD. Importantly, CSF biomarkers, personality, depression, anxiety, and ApoE genotype show complementary value for classification of AD and its at-risk stages.Key Points– Multi-class support vector machine classification was used to compare the predictive value of well-established and non-invasive, easy-to-assess candidate variables for classifying participants with healthy cognition, subjective cognitive decline, amnestic mild cognitive impairment, and mild Alzheimer’s disease.– Personality traits, geriatric anxiety and depression scores, resting-state functional magnetic resonance imaging activity of the default mode network, ApoE genotype, and CSF biomarkers were comparatively evaluated.– A combination of personality, anxiety, and depression scores provided the highest predictive accuracy, comparable to CSF biomarkers, indicating complementary value.– Established and candidate predictors had limited success in classifying SCD and aMCI, underscoring the heterogeneity of these cognitive states and emphasizing the need for standardizing terminology and diagnostic criteria.Competing Interest StatementF. Jessen received fees for consultations and presentations between 2019 and 2022 from AC Immune, Biogen, Danone/Nutricia, Eisai, GE Healthcare, Grifols, Janssen, Lilly, MSD, Novo Nordisk, and Roche. E. Düzel is cofounder of neotiv GmbH. The remaining authors report no disclosures relevant to the manuscript.Clinical Protocols https://drks.de/search/de/trial/DRKS00007966 Funding StatementThe study was funded by the German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen [DZNE]), reference number BN012.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by Institutional Review Boards of all participating study centers of the DZNE. The process was led and coordinated by the ethical committee of the medical faculty of the University of Bonn (registration number 117/13).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll scripts used to perform the analyses are available under https://github.com/jmkizilirmak/DELCODE162. Data can be made available to cooperation partners of the DZNE after setting up appropriate data sharing contracts. https://github.com/jmkizilirmak/DELCODE162